Erste Group Bank Brokers Increase Earnings Estimates for UNH

UnitedHealth Group Incorporated (NYSE:UNH) – Research analysts at Erste Group Bank raised their FY2027 earnings per share estimates for shares of UnitedHealth Group in a research note issued to investors on Tuesday, March 24th. Erste Group Bank analyst H. Engel now anticipates that the healthcare conglomerate will post earnings per share of $19.77 for the year, up from their previous estimate of $19.71. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.54 per share.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the company posted $6.81 EPS. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS.

A number of other analysts also recently issued reports on the stock. Oppenheimer cut their price objective on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Leerink Partners dropped their price objective on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Trading Down 0.7%

Shares of UnitedHealth Group stock opened at $270.48 on Thursday. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $606.36. The stock has a market cap of $245.51 billion, a PE ratio of 20.51, a PEG ratio of 1.25 and a beta of 0.41. The firm has a 50-day moving average of $293.25 and a 200-day moving average of $323.43. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC increased its holdings in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group during the 4th quarter worth $27,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.3%. UnitedHealth Group’s payout ratio is 67.02%.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH is expanding AI investments to drive efficiency and margin improvement; management reiterated growth and operational-improvement priorities at conferences, which supports medium-term profitability. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Recent quarterly results showed a small EPS beat and revenue growth year-over-year; that underlying earnings strength and management’s reiterated guidance provide a constructive earnings foundation (supports analyst valuation).
• Neutral Sentiment: Wall Street analysts remain broadly bullish on UNH (average brokerage recommendation favors buying), which can prop up the stock, though the coverage is noted as often optimistic and may have limited immediate impact. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Industry hiring and AI-focused vendor moves (e.g., executive hiring at an AI-driven claims remediation firm) highlight sector innovation trends that could indirectly benefit large payor/Optum capabilities, but impact on UNH’s near-term stock trajectory is unclear. Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
• Negative Sentiment: The DOJ has intensified an antitrust probe into Optum and UnitedHealth’s integrated model; heightened regulatory scrutiny raises headline risk, potential remedies, and valuation uncertainty for UNH. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: A proposed settlement in an insulin pricing case would leave CVS Caremark settled while UnitedHealth remains the sole holdout, underscoring litigation and competitive risks that could lead to future costs or reputational impacts if UNH becomes a target. CVS, FTC reach proposed settlement in insulin pricing case

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.